Share Your Research, Maximize Your Social Impacts
Immunomodulation with Thymalin in the COVID-19 Related Cytokine Storm: Case Reports |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.10, No. 6)Publication Date: 2020-11-06
Authors : Shapovalov Konstantin G; Kuznik Boris I; Lukyanov Sergey A; Khavinson Vladimir K; Smolyakov Yuri N; Tereshkov Pavel K; Shapovalov Yuri K; Konnov Valery A; Magen Eli;
Page : 557-564
Keywords : Case; Report; Thymalin; Immunomodulation; COVID-19;
Source : Download
Find it from : Google Scholar
Abstract
Background: Immunosuppression and “Cytokine storm” in severe coronavirus disease (COVID-19) occur almost simultaneously. The elderly persons with COVID-19 are at high risk for uncontrolled cytokine storm and deep immunosuppression. Thymalin, polypeptide medication obtained from the calf thymus may be used in the treatment of severe COVID-19 patients, using immunomodulatory therapy.
Other Latest Articles
- Analysis of the long-term temperature trends in the Kofarnihon river basin in Tajikistan
- Modernization of the system for ensuring the stability of the railroad crane KZh-971 and evaluation of its effectiveness
- The results of studies of the rigidity of stabilizers and the roll angle of the truck
- Organic Agriculture makes People Healthier |Biomedgrid
- Force calculation of the fastening mechanism of the end tower of a mobile transport and reloading rope unit using a holding rope
Last modified: 2023-07-07 21:49:40